docetaxel anhydrous has been researched along with inositol in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (inositol) | Trials (inositol) | Recent Studies (post-2010) (inositol) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 8,268 | 400 | 2,050 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | inositol (IC50) |
|---|---|---|---|
| Chain B, Pulmonary surfactant-associated protein D | Homo sapiens (human) | 5700 | |
| Chain A, Pulmonary surfactant-associated protein D | Homo sapiens (human) | 5700 | |
| Sodium/myo-inositol cotransporter 2 | Homo sapiens (human) | 104 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulikas, T; Erdmann, R; Fedier, A; Fink, D | 1 |
1 other study(ies) available for docetaxel anhydrous and inositol
| Article | Year |
|---|---|
Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antineoplastic Agents; Base Pair Mismatch; Carrier Proteins; Chromones; Cisplatin; Colorectal Neoplasms; DNA Repair; Docetaxel; Drug Resistance, Neoplasm; Humans; Inositol; Morpholines; MutL Protein Homolog 1; Nuclear Proteins; Organoplatinum Compounds; Oxaliplatin; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Taxoids; Tumor Cells, Cultured | 2006 |